Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Int J Surg Case Rep ; 93: 106989, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35367951

RESUMO

OBJECTIVES: Parathyroid cysts are rare benign lesions of the head and neck that account for less than 1% of cystic neck masses. We present a rare case of a large 6 cm substernal parathyroid cyst. PRESENTATION OF CASE: An otherwise healthy 65 year-old female presented to the otolaryngology clinic for evaluation of an anterior, midline neck mass. On physical exam, she was noted to have a fullness in the anterior neck extending to the sternal notch. CT demonstrated an enlarged thyroid with a cyst extending to the aortic arch. Initial evaluation suggested a bilateral goiter with substernal extension. The cyst was managed with drainage and observation. After two years of continued growth, the patient underwent a left thyroid lobectomy and mediastinal mass resection via the cervical approach. Final pathology was consistent with a parathyroid cyst. CONCLUSIONS: Parathyroid cysts are a rare cause of neck mass in an adult, and a 6 cm substernal parathyroid cyst represents an unusual site and size for these cysts. Parathyroid cysts are not often considered on the differential of neck and mediastinal cystic lesions. However, appropriate steps should be taken to ensure a proper diagnosis for any cystic lesion in the neck.

2.
Otolaryngol Head Neck Surg ; 163(1): 42-46, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32340546

RESUMO

Performance of tracheotomy is a potential necessary step in the patient with coronavirus disease 19 (COVID-19) and prolonged mechanical ventilation. Due to viral aerosolization, tracheotomy carries a high risk of transmission of COVID-19 to the health care team performing the procedure. We share our institution's surgical safety checklist for performing tracheotomy in patients with COVID-19, including key modifications intended to mitigate risk to the surgical team.


Assuntos
Betacoronavirus , Infecções por Coronavirus/complicações , Transmissão de Doença Infecciosa/prevenção & controle , Pandemias , Pneumonia Viral/complicações , Insuficiência Respiratória/terapia , Traqueotomia/normas , COVID-19 , Lista de Checagem , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/transmissão , Humanos , Pneumonia Viral/epidemiologia , Pneumonia Viral/transmissão , Respiração Artificial/métodos , Respiração Artificial/normas , Insuficiência Respiratória/etiologia , SARS-CoV-2 , Resultado do Tratamento
3.
Head Neck ; 40(4): 784-792, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29356169

RESUMO

BACKGROUND: Oral cavity squamous cell carcinoma (SCC) arising in nonsmokers and nondrinkers remains poorly characterized. We hypothesized that these patients had prior exposure to metallic dental hardware. METHODS: We utilized a questionnaire querying the lifetime oral health status of 54 patients. Demographics and extensive oral health history were collected. RESULTS: The majority of patients (74%) had prior exposure to metallic dental hardware. The younger population with almost exclusively oral tongue cancer had a high prevalence of metallic orthodontic braces (40%) within 15 years before diagnosis. In the 51+ year age group, 82% had crowns, dental implants, and/or dentures with metallic elements. CONCLUSION: Exposure to metallic dental hardware has increased in the past few decades given the rise of orthodontic braces and older adults retaining more teeth. Although this study does not prove a causal relationship between oral cavity SCC and dental hardware, this is a step toward identifying and investigating their role.


Assuntos
Ligas Dentárias/efeitos adversos , Estilo de Vida , Neoplasias Bucais/etiologia , Aparelhos Ortodônticos/efeitos adversos , Carcinoma de Células Escamosas de Cabeça e Pescoço/etiologia , Adolescente , Adulto , Fatores Etários , Idoso , Consumo de Bebidas Alcoólicas , Estudos de Coortes , Intervalos de Confiança , Feminino , Humanos , Incidência , Masculino , Metais/efeitos adversos , Pessoa de Meia-Idade , Neoplasias Bucais/epidemiologia , Neoplasias Bucais/fisiopatologia , não Fumantes , Saúde Bucal , Prognóstico , Estudos Retrospectivos , Fatores de Risco , Fatores Sexuais , Carcinoma de Células Escamosas de Cabeça e Pescoço/epidemiologia , Carcinoma de Células Escamosas de Cabeça e Pescoço/fisiopatologia , Inquéritos e Questionários , Neoplasias da Língua/epidemiologia , Neoplasias da Língua/etiologia , Neoplasias da Língua/fisiopatologia , Estados Unidos , Adulto Jovem
4.
Am J Med ; 118 Suppl 7A: 45S-50S, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15993677

RESUMO

Rhinosinusitis is one of the most common respiratory tract conditions seen by primary care physicians. Each year approximately 20 million cases of acute bacterial rhinosinusitis (ABRS) occur in the United States. Since diagnosis of ABRS relies on clinical evaluation, treatments are usually empirical and include an antibiotic treatment that covers the common bacteria associated with ABRS infection, Streptococcus pneumoniae and Haemophilus influenzae. The Council for Appropriate and Rational Antibiotic Therapy (CARAT) recommends that antimicrobial therapy for rhinosinusitis should combine high susceptibility, clinical effectiveness, safety, and tolerability. The most efficacious antibiotics for ABRS include the respiratory fluoroquinolones gatifloxacin, levofloxacin, and moxifloxacin, as well as ceftriaxone and amoxicillin-clavulanate. The use of fluoroquinolones or high-dose amoxicillin-clavulanate is recommended for patients with mild disease who have had recent antimicrobial therapy or for patients with moderate disease. These drugs are generally well tolerated with mild adverse effects. Resistance to fluoroquinolones in S pneumoniae and H influenzae has remained low in spite of their increased use. Recent studies indicate that short-course, high-dose treatment regimens may reduce total drug use, improve tolerability and adherence, prevent increases in resistance, and increase efficacy. The use of fluoroquinolones or amoxicillin-clavulanate in a short-course, high-dose regimen may represent an exciting new protocol in the treatment of rhinosinusitis.


Assuntos
Assistência Ambulatorial , Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Rinite/tratamento farmacológico , Sinusite/tratamento farmacológico , Antibacterianos/economia , Antibacterianos/farmacocinética , Humanos , Guias de Prática Clínica como Assunto , Rinite/complicações , Rinite/microbiologia , Sinusite/complicações , Sinusite/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA